SAB Biotherapeutics- Warrants (25/07/2027) Current Assets

SAB Biotherapeutics- Warrants (25/07/2027) (SABSW) currently reports a current assets of $110M as of March 2026. That compares with $16M in the prior-year period — up 592.1% year over year. Use the charts on this page to explore SAB Biotherapeutics- Warrants (25/07/2027)'s current assets history and peer comparisons.

SAB Biotherapeutics- Warrants (25/07/2027)'s current assets increased from $16M to $110M — a 592.1% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

SAB Biotherapeutics- Warrants (25/07/2027) reported $110M in current assets as of March 2026. That compares with $16M in the prior-year period — up 592.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $110M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for SAB Biotherapeutics- Warrants (25/07/2027), and consider following SABSW for alerts when major investors trade the stock.